Abdun-Nabi Daniel
Insider CIK 1380187 · EBS President and CEO, Director · RGNX Director · APVO Board of Directors, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 400 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 400 | — | $0 | 400 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 400 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 400 | — | — | 400 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2025-08-06 | 2025-08-08 | 7,200 | — | $0 | 7,200 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2025-07-17 | 2025-07-21 | 1 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2025-07-17 | 2025-07-21 | 1 | — | $0 | 1 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2024-07-17 | 2024-07-19 | 925 | — | $0 | 925 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-06-02 | 2024-06-03 | 81 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-06-02 | 2024-06-03 | 81 | — | $0 | 277 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-06-01 | 2024-06-03 | 7 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-06-01 | 2024-06-03 | 7 | — | $0 | 196 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-08-09 | 2023-08-10 | 3,571 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-08-09 | 2023-08-10 | 3,571 | — | $0 | 8,339 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2023-06-02 | 2023-06-02 | 3,571 | — | $0 | 3,571 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-06-01 | 2023-06-02 | 297 | — | $0 | 298 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-06-01 | 2023-06-02 | 297 | — | $0 | 4,768 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2022-08-09 | 2022-08-10 | 3,571 | — | $0 | 3,571 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2022-06-01 | 2022-06-03 | 298 | — | $0 | 595 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2022-06-01 | 2022-06-03 | 298 | — | $0 | 8,108 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2021-06-04 | 2021-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-06-01 | 2021-06-02 | 2,678 | — | $0 | 2,678 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-06-01 | 2021-06-02 | 893 | — | $0 | 893 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 170 | — | $0 | 170 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 1,339 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 892 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 1,785 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 1,322 | — | $0 | 1,322 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-02 | 2021-02-17 | 3,571 | — | $0 | 3,571 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2020-05-29 | 2020-06-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-06-25 | 2019-06-25 | 16,667 | $0.90 | $15.0K | 109,351 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2019-06-01 | 2019-06-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2019-05-31 | 2019-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2019-03-04 | 2019-03-04 | 14,565 | $58.11 | $846.4K | 142,617 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2019-02-28 | 2019-02-28 | 5,101 | $58.71 | $299.5K | 157,182 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2019-02-27 | 2019-02-28 | 2,570 | $57.98 | $149.0K | 162,283 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2019-02-26 | 2019-02-28 | 1,714 | $61.01 | $104.6K | 164,853 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2018-09-17 | 2018-09-18 | 1,319 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-09-17 | 2018-09-18 | 1,319 | $65.00 | $85.7K | 166,567 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2018-09-17 | 2018-09-18 | 1,319 | $13.38 | $17.6K | 167,886 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2018-09-14 | 2018-09-18 | 28,220 | — | $0 | 1,319 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2018-09-14 | 2018-09-18 | 28,220 | $13.38 | $377.6K | 194,787 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-09-14 | 2018-09-18 | 28,220 | $65.00 | $1.83M | 166,567 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-09-05 | 2018-09-06 | 30,776 | $59.49 | $1.83M | 166,567 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2018-09-04 | 2018-09-06 | 60,000 | — | $0 | 29,539 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-09-04 | 2018-09-06 | 60,000 | $60.54 | $3.63M | 197,343 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2018-09-04 | 2018-09-06 | 60,000 | $13.38 | $802.8K | 257,343 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-06-05 | 2018-06-07 | 15,785 | $52.11 | $822.6K | 197,343 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2018-06-01 | 2018-06-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2018-05-25 | 2018-05-30 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2018-03-09 | 2018-03-13 | 7,825 | $51.84 | $405.6K | 213,128 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2018-02-28 | 2018-03-01 | 6,599 | $49.97 | $329.8K | 220,953 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2018-02-27 | 2018-03-01 | 53,485 | $49.64 | $2.65M | 53,485 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2018-02-27 | 2018-03-01 | 3,324 | $49.64 | $165.0K | 227,552 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2018-02-27 | 2018-03-01 | 13,371 | — | $0 | 230,876 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2018-02-27 | 2018-03-01 | 13,371 | — | $0 | 217,505 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2018-01-02 | 2018-01-04 | 21,906 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2018-01-02 | 2018-01-04 | 21,906 | $47.91 | $1.05M | 204,134 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2018-01-02 | 2018-01-04 | 21,906 | $14.44 | $316.3K | 226,040 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-12-13 | 2017-12-14 | 20,000 | — | $0 | 21,906 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-12-13 | 2017-12-14 | 20,000 | $14.44 | $288.8K | 224,134 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-12-13 | 2017-12-14 | 20,000 | $45.99 | $919.8K | 204,134 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-11-03 | 2017-11-07 | 20,000 | — | $0 | 41,906 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-11-03 | 2017-11-07 | 11,508 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-11-03 | 2017-11-07 | 20,000 | $42.92 | $858.4K | 204,134 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-11-03 | 2017-11-07 | 20,000 | $14.44 | $288.8K | 224,134 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-11-03 | 2017-11-07 | 11,508 | $22.03 | $253.5K | 215,642 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-11-03 | 2017-11-07 | 11,508 | $42.50 | $489.1K | 204,134 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-09-27 | 2017-09-29 | 15,000 | — | $0 | 11,508 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-09-27 | 2017-09-29 | 15,000 | $39.92 | $598.8K | 204,134 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-09-27 | 2017-09-29 | 15,000 | $22.03 | $330.4K | 219,134 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-08-31 | 2017-09-05 | 15,000 | — | $0 | 26,508 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-08-31 | 2017-09-05 | 15,000 | $37.21 | $558.1K | 204,134 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-08-31 | 2017-09-05 | 15,000 | $22.03 | $330.4K | 219,134 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2017-06-01 | 2017-06-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2017-05-24 | 2017-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2017-03-10 | 2017-03-10 | 10,738 | $31.05 | $333.4K | 204,134 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2017-03-09 | 2017-03-10 | 8,226 | $30.98 | $254.8K | 214,872 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2017-02-28 | 2017-03-02 | 78,329 | $30.63 | $2.40M | 78,329 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2017-02-28 | 2017-03-02 | 19,589 | — | $0 | 229,282 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 6,184 | $30.63 | $189.4K | 223,098 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2017-02-28 | 2017-03-02 | 19,588 | — | $0 | 209,693 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-02-27 | 2017-03-01 | 3,662 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2017-02-27 | 2017-03-01 | 984 | $30.63 | $30.1K | 190,105 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2017-02-27 | 2017-03-01 | 1,735 | $30.63 | $53.1K | 191,089 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-02-27 | 2017-03-01 | 3,662 | $30.63 | $112.2K | 192,824 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2017-01-10 | 2017-01-12 | 38,006 | — | $0 | 3,662 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2017-01-10 | 2017-01-12 | 28,240 | $31.28 | $883.3K | 189,162 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2017-01-10 | 2017-01-12 | 38,006 | $14.51 | $551.5K | 217,402 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2016-08-05 | 2016-08-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2016-08-03 | 2016-08-05 | 18,750 | — | $0 | 18,750 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other deriv | 2016-08-01 | 2017-01-12 | 3,662 | — | $0 | 41,668 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2016-08-01 | 2017-01-12 | 3,032 | — | $0 | 175,977 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2016-08-01 | 2017-01-12 | 1,979 | — | $0 | 172,945 | SEC↗ |
| EBS Emergent BioSolutions Inc. | J Other | 2016-08-01 | 2017-01-12 | 3,419 | — | $0 | 179,396 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-06-01 | 2016-06-03 | 8,699 | $43.74 | $380.5K | 170,966 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-05-20 | 2016-05-24 | 8,701 | $42.00 | $365.4K | 179,665 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-04-18 | 2016-04-20 | 3,580 | $40.17 | $143.8K | 190,739 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-04-18 | 2016-04-20 | 2,373 | $40.17 | $95.3K | 188,366 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-04-18 | 2016-04-20 | 2,749 | $40.17 | $110.4K | 194,319 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2016-03-11 | 2016-04-05 | 6,493 | $34.22 | $222.2K | 197,068 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2016-03-10 | 2016-03-11 | 9,794 | $34.38 | $336.7K | 203,561 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2016-03-09 | 2016-03-11 | 7,484 | $34.60 | $258.9K | 213,355 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2016-03-01 | 2016-03-03 | 70,922 | — | $0 | 70,922 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2016-03-01 | 2016-03-03 | 35,471 | — | $0 | 220,839 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2015-12-24 | 2015-12-28 | 22,855 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2015-12-24 | 2015-12-28 | 22,855 | $18.90 | $432.0K | 208,223 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-12-24 | 2015-12-28 | 22,855 | $39.17 | $895.2K | 185,368 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2015-12-23 | 2015-12-28 | 40,354 | — | $0 | 22,855 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2015-12-23 | 2015-12-28 | 40,354 | $18.90 | $762.7K | 225,722 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2015-12-23 | 2015-12-28 | 40,354 | $38.99 | $1.57M | 185,368 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2015-12-15 | 2015-12-17 | 4,140 | — | $0 | 37,860 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2015-12-15 | 2015-12-17 | 2,641 | $37.87 | $100.0K | 185,368 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2015-12-15 | 2015-12-17 | 4,140 | $24.15 | $100.0K | 188,009 | SEC↗ |
| EBS Emergent BioSolutions Inc. | G Gift | 2015-05-14 | 2015-05-15 | 936 | — | $0 | 183,869 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2015-03-12 | 2015-03-12 | 4,490 | $28.67 | $128.7K | 184,805 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2015-03-11 | 2015-03-12 | 6,493 | $28.99 | $188.2K | 189,295 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2015-03-10 | 2015-03-12 | 94,344 | — | $0 | 94,344 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2015-03-10 | 2015-03-12 | 9,779 | $29.00 | $283.6K | 195,788 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2015-03-10 | 2015-03-12 | 47,188 | — | $0 | 205,567 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2014-12-24 | 2014-12-29 | 5,291 | — | $0 | 63,209 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2014-12-24 | 2014-12-29 | 6,285 | — | $0 | 38,006 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2014-12-24 | 2014-12-29 | 5,291 | $18.90 | $100.0K | 159,330 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2014-12-24 | 2014-12-29 | 6,285 | $15.91 | $100.0K | 165,615 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2014-12-24 | 2014-12-29 | 7,236 | $27.64 | $200.0K | 158,379 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2014-05-31 | 2014-10-16 | 506 | $18.44 | $9.3K | 154,039 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2014-03-14 | 2014-03-18 | 2,248 | $27.06 | $60.8K | 155,533 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2014-03-12 | 2014-03-13 | 3,021 | $27.15 | $82.0K | 157,781 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2014-03-11 | 2014-03-12 | 123,192 | — | $0 | 123,192 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2014-03-11 | 2014-03-12 | 61,596 | — | $0 | 160,802 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2014-03-11 | 2014-03-12 | 4,347 | $28.09 | $122.1K | 99,206 | SEC↗ |
| EBS Emergent BioSolutions Inc. | P Buy | 2013-11-30 | 2013-12-09 | 749 | $19.08 | $14.3K | 103,373 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2013-11-07 | 2013-11-12 | 4,613 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2013-11-07 | 2013-11-12 | 4,613 | $10.13 | $46.7K | 100,624 | SEC↗ |
| EBS Emergent BioSolutions Inc. | P Buy | 2013-05-31 | 2013-06-04 | 800 | $12.07 | $9.7K | 96,011 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2013-03-14 | 2013-03-18 | 2,248 | $14.46 | $32.5K | 95,211 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2013-03-12 | 2013-03-12 | 81,669 | — | $0 | 81,669 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2013-03-12 | 2013-03-12 | 40,834 | — | $0 | 97,459 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2013-03-12 | 2013-03-12 | 3,201 | $14.67 | $47.0K | 56,625 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2013-03-08 | 2013-03-12 | 2,304 | $15.22 | $35.1K | 59,826 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2012-12-27 | 2012-12-28 | 7,300 | — | $0 | 4,613 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2012-12-27 | 2012-12-28 | 4,677 | $15.81 | $73.9K | 62,148 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2012-12-27 | 2012-12-28 | 7,300 | $10.13 | $73.9K | 66,825 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2012-03-14 | 2012-03-16 | 2,185 | $16.05 | $35.1K | 59,525 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2012-03-13 | 2012-03-16 | 56,500 | — | $0 | 56,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2012-03-13 | 2012-03-16 | 28,250 | — | $0 | 61,710 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2012-03-08 | 2012-03-12 | 2,303 | $14.49 | $33.4K | 33,460 | SEC↗ |